These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 350137)

  • 1. Adjuvant chemoimmunotherapy with LMF + BCG in node-negative and node-positive breast cancer patients. Intermediate report of a randomized trial in 242 patients.
    Senn HJ; Jungi WF; Amgwerd R; Sprenger F; Hochueli R; Engelhart G; Heinz C; Wick A; Enderlin F; Creux G; Simeon B; Lanz R; Bigler R
    Antibiot Chemother (1971); 1978; 24():213-28. PubMed ID: 350137
    [No Abstract]   [Full Text] [Related]  

  • 2. Swiss adjuvant trial (OSAKO 06/74) with chlorambucil, methotrexate, and 5-fluorouracil plus BCG in node-negative breast cancer patients: nine-year results.
    Senn HJ; Jungi WF; Amgwerd R; Hochuli E; Ammann J; Engelhart G; Heinz C; Wick A; Enderlin F; Creux G
    NCI Monogr; 1986; (1):129-34. PubMed ID: 3534585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Divergent effect of adjuvant chemo-immunotherapy on recurrence rates in node-negative and node-positive breast cancer patients.
    Jungi WF; Senn HJ; Amgwerd R; Hochuli E
    Eur J Cancer (1965); 1980; Suppl 1():169-72. PubMed ID: 7032928
    [No Abstract]   [Full Text] [Related]  

  • 4. Adjuvant chemoimmunotherapy with LMF plus BCG in node-negative and node-positive breast cancer - intermediate report at 4 years.
    Senn HJ; Amgwerd R; Jungi WF; Hochuli R; Ammann J; Engelhart G; Heinz C; Wick A; Enderlin F; Creux G; Simon B; Lanz R; Bigler R; Seiler S
    Recent Results Cancer Res; 1982; 80():177-84. PubMed ID: 7036281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Swiss adjuvant trials in women with node-negative breast cancer. OSAKO.
    Jungi WF; Senn HJ
    J Natl Cancer Inst Monogr; 1992; (11):71-6. PubMed ID: 1627433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant chemoimmunotherapy with LMF + BCG in node-negative and node-positive breast cancer patients: 10 year results.
    Senn HJ; Barett-Mahler AR; Jungi WF; Osako
    Eur J Cancer Clin Oncol; 1989 Mar; 25(3):513-25. PubMed ID: 2703006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant chemo-immuno-therapy with LMF+BCG in node-negeative and node-positive breast cancer.
    Senn HJ; Jungi WF; Amgwerd R; Sprenger F; Hochuli E; Engelhart G; Heinz C; Wick A; Enderlin F; Simeon B; Lanz R; Bigler R
    Haematol Blood Transfus; 1978; 22():47-60. PubMed ID: 374199
    [No Abstract]   [Full Text] [Related]  

  • 8. Adjuvant chemoimmunotherapy with LMF + BCG in node-negative and node-positive breast cancer: 8 year results.
    Senn HJ; Jungi WF; Amgwerd R; Hochuli E; Ammann J; Engelhart G; Heinz C; Wick A; Enderlin F; Creux G
    Recent Results Cancer Res; 1984; 96():90-101. PubMed ID: 6528092
    [No Abstract]   [Full Text] [Related]  

  • 9. [Adjuvant chemotherapy in breast cancer: status in 1984].
    Jungi WF
    Wien Klin Wochenschr; 1984 Jun; 96(13):486-92. PubMed ID: 6382805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant chemotherapy with chlorambucil and 5-fluorouracil in primary breast cancer (Cooperative Study Heidelberg).
    Kaufmann M; Fournier DV; Sievers H; Staib I; Wöllgens P; Nedden R; Lochbühler H; Queisser W; Christmann D; Bühner R; Pfuhl PJ; Henningsen B; Kuttig H; Wysocki S; Thüre D; Köhler C; Drings P
    Eur J Cancer (1965); 1980; Suppl 1():157-60. PubMed ID: 7032925
    [No Abstract]   [Full Text] [Related]  

  • 11. Surgery and adjuvant chemotherapy in the treatment of operable breast cancer.
    Rossi A; Valagussa P; Bonadonna G
    Prog Clin Biol Res; 1977; 12():391-404. PubMed ID: 335401
    [No Abstract]   [Full Text] [Related]  

  • 12. West Midlands Oncology Association trial of adjuvant chemotherapy in node-negative breast cancer.
    Morrison JM; Kelly KA; Howell A; Grieve RJ; Monypenny IJ; Walker RA; Waterhouse JA
    J Natl Cancer Inst Monogr; 1992; (11):85-8. PubMed ID: 1627435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
    Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
    Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant chemotherapy, anti-estrogen therapy and immunotherapy for stage II breast cancer.
    Hubay CA; Pearson OH; Marshall JS; Rhodes RS; Debanne SM; Mansour EG; Hermann RE; Jones JC; Flynn WJ; Eckert C; McGuire WL
    Eur J Cancer (1965); 1980; Suppl 1():189-95. PubMed ID: 7032932
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup study.
    Mansour EG; Gray R; Shatila AH; Osborne CK; Tormey DC; Gilchrist KW; Cooper MR; Falkson G
    N Engl J Med; 1989 Feb; 320(8):485-90. PubMed ID: 2915651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short- or long-term chemotherapy for node-positive breast cancer: LMF 6 versus 18 cycles. SAKK study 27/76.
    Jungi WF; Alberto P; Brunner KW; Mermillod B; Barrelet L; Cavalli F
    Recent Results Cancer Res; 1984; 96():175-7. PubMed ID: 6396771
    [No Abstract]   [Full Text] [Related]  

  • 17. The case for adjuvant CMF chemotherapy in breast cancer. Has it been made?
    Levitt SH; Potish RA
    Cancer Clin Trials; 1981; 4(4):363-9. PubMed ID: 7032731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of five drug combination chemotherapy in the management of recurrent carcinoma of the breast.
    Lee JM; Abeloff MD; Lenhard RE; Baker RR
    Surg Gynecol Obstet; 1974 Jan; 138(1):77-80. PubMed ID: 4809006
    [No Abstract]   [Full Text] [Related]  

  • 19. Natural history of more than 20 years of node-positive primary breast carcinoma treated with cyclophosphamide, methotrexate, and fluorouracil-based adjuvant chemotherapy: a study by the Cancer and Leukemia Group B.
    Weiss RB; Woolf SH; Demakos E; Holland JF; Berry DA; Falkson G; Cirrincione CT; Robbins A; Bothun S; Henderson IC; Norton L;
    J Clin Oncol; 2003 May; 21(9):1825-35. PubMed ID: 12721260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiestrogen-cytotoxic chemotherapy and bacillus Calmette-Guerin vaccination in stage II breast cancer: seventy-two-month follow-up.
    Hubay CA; Gordon NH; Crowe JP; Guyton SP; Pearson OH; Marshall JS; Mansour EG; Hermann RE; Jones JC; Flynn WJ
    Surgery; 1984 Jul; 96(1):61-72. PubMed ID: 6740497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.